Medesis Pharma S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was EUR 0.267547 million. Net loss was EUR 1.62 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.918 EUR | +0.88% | +0.88% | +5.76% |
Jun. 05 | MEDESIS : Invest Securities confirms its 'neutral' rating | CF |
2023 | Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+5.76% | 4.34M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- ALMDP Stock
- News Medesis Pharma S.A.
- Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023